iGan Partners
Venture capitalToronto · Seed–Late Stage · 7 people tracked
Investment thesis
iGan Partners focuses on early-stage healthcare companies, particularly those leveraging artificial intelligence in medical technology and digital health. The firm emphasizes long-term company building with hands-on operational support, bringing together entrepreneurs, company builders, and operators to provide not just capital but also talent, management expertise, and resources to help portfolio companies scale from seed through Series A and beyond to exit.
Source: firm website, verified Jul 21, 2026.
Team · 7 people
from the firm's websiteSam Ifergan is the founder and leader of iGan Partners. He has a background as an engineer who transitioned to entrepreneurship and then to investing, bringing deep domain expertise in healthcare technology commercialization to the firm.
Investments · 29 tracked
founders shown can be your intro pathPortfolio company that received lead investment and ongoing support from iGan Partners across multiple funding rounds.
Company developing innovative disruptive technology for healthcare commercialization, supported by iGan Partners as a first major investor.
Medical technology company founded by Ralph DaCosta that received early-stage capital and entrepreneurial mentorship from iGan Partners.
Frequently asked questions
- What stage does iGan Partners invest at?
- iGan Partners invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does iGan Partners focus on?
- iGan Partners focuses on AI & Machine Learning, Digital Health, Healthtech, Medical Devices.
- Where is iGan Partners located?
- iGan Partners is headquartered in Toronto, CA.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.